Finasteride carboxaldehyde

• Description :

  Finasteride carboxaldehyde (Compound M2) is the metabolite of 5α-reductase inhibitor Finasteride (HY-13635) in human bile and urine[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  Endogenous Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/finasteride-carboxaldehyde.html

• Solubility :

  10 mM in DMSO

• Smiles :

  C[C@@]12[C@](CC[C@@H]2C(NC(C)(C)C=O)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4([C@@](NC(C=C4)=O)([H])CC3)C

• Molecular Formula :

  C23H34N2O3

• Molecular Weight :

  386.53

• Precautions :

  P261-P280-P302+P352

• References & Citations :

  [1]Lundahl A, et al., Identification of finasteride metabolites in human bile and urine by high-performance liquid chromatography/tandem mass spectrometry. Drug Metab Dispos. 2009 Oct;37 (10) :2008-17.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [154387-61-8]